US Biotech Race: Urgency Needed to Maintain Lead Over China, Experts Warn
Forbes Breaking NewsNovember 7, 20255 min1,355 views
14 connectionsΒ·19 entities in this videoβThe US Biotech Advantage and China's Rise
- πΊπΈ John F. Crowley states that the US is currently the leading country in biotechnology, but China is a significant and rapidly growing competitive threat.
- β οΈ Crowley warns that the US could lose its leading edge in biotechnology within 2 to 3 years if action is not taken boldly and immediately.
- π The share of innovative medicines from China has surged from 2% a decade ago to approximately 25% today.
Urgency and Government Response
- ποΈ Sen. Andy Kim emphasizes the need for the committee and the country to embrace the urgency of the current moment in the biotech race.
- π Experts suggest the nation is not operating with the necessary level of urgency across government and industry.
- π There's a concern that research is moving to other countries due to a regulatory system and ecosystem that doesn't allow for faster trials in the US.
FDA Resources and Staffing
- π§ββοΈ The FDA's current resources and staffing are questioned regarding their ability to meet the urgency of maintaining a global biotech lead.
- π οΈ Improvements suggested include refilling vacancies one-to-one, deploying the latest technologies in reviews, and reinforcing US scientific and clinical infrastructure.
- βοΈ Supporting intellectual property and combating infringing entities, primarily from China, is crucial for US competitiveness.
Accelerating Innovation with AI
- π€ The innovative use of Artificial Intelligence (AI) is identified as a key factor to supercharge research and development.
- π AI can significantly reduce the time and expense of drug discovery and expedite compounds moving into clinical trials.
- π€ Leveraging AI within clinical trial infrastructure can help with decentralized trials and trial recruitment, making the US system more competitive.
The Human Element of Biotech
- β€οΈ The urgency in biotech is framed not just for economic or geostrategic reasons, but for the urgency of saving lives, akin to a parent trying to save their child.
- π The ultimate goal is the nation's ability to save millions of lives both domestically and globally.
Knowledge graph19 entities Β· 14 connections
How they connect
An interactive map of every person, idea, and reference from this conversation. Hover to trace connections, click to explore.
Hover Β· drag to explore
19 entities
Chapters3 moments
Key Moments
Transcript20 segments
Full Transcript
Topics12 themes
Whatβs Discussed
BiotechnologyChinaUS CompetitivenessUrgencyFDARegulatory SystemClinical TrialsArtificial IntelligenceDrug DiscoveryIntellectual PropertyScientific InfrastructureNational Security
Smart Objects19 Β· 14 links
ConceptsΒ· 13
LocationΒ· 1
MediaΒ· 1
ProductΒ· 1
EventsΒ· 3